GGrantScoutHQFind grants
← Back to grants

Limited Competition: Institutional Development Award (IDeA) for Clinical & Translational Research (CTR) (P30 - CT Optional)

National Institutes of Health

The Institutional Development Award (IDeA) program develops biomedical research capacity in states that have historically received low levels of NIH funding (IDeA states). The IDeA Clinical & Translational Research (CTR) program supports two programmatic tracks to build clinical and translationa

Funding
Varies
Category
Health & Medical
Status
OPEN
Deadline
5/31/2029

About

The Institutional Development Award (IDeA) program develops biomedical research capacity in states that have historically received low levels of NIH funding (IDeA states). The IDeA Clinical & Translational Research (CTR) program supports two programmatic tracks to build clinical and translational (C&T) research capacity to enable research on diseases and health challenges prevalent in IDeA states. IDeA CTR Development (CTR-D) awards focus on C&T research workforce development and infrastructure enhancement at health research organizations with limited clinical research capacity in IDeA states. IDeA CTR Network (CTR-N) awards support statewide (or multi-state) networks of health research organizations to expand existing infrastructure, develop the research workforce to enhance the network organization's ability to design and implement competitive C&T research programs, and coordinate clinical research activities state-wide and/or across IDeA states.This is a Notice of Funding Opportunity (NOFO) for a Limited Competition that will invite application(s) from eligible organization(s) to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered.

Eligibility

Eligibility Criteria for Lead and Partner OrganizationsEvery organization in the application must be either a Lead or a Partner–no organization can be both.Every organization in the application must be in an IDeA-eligible state.There are strict limits to avoid overlap:Each IDeA-eligible state can only have one active IDeA-CTR-type (IDeA-CTR, CTR-N, or CTR-D) award at a time.An organization can only be involved in one IDeA-CTR-type award at a time.Organizations may not serve as a lead, partner or otherwise participate with an active Clinical and Translational Science Award (CTSA). Organizations must meet all eligibility rules at the time of application submission and award.Additional Eligibility Criteria for Lead OrganizationsTo apply as the lead, the organization must:Already have externally-funded clinical and translational (C&T) research.Additional Eligibility Criteria for Partner OrganizationsTo participate as a partner, the organization mustBe in the same state or multi-state region as the lead organization.Note:Active awards include awards in no-cost extension (NCE).An organization that currently leads an active IDeA-CTR-type award may submit a new application if substantial changes to the CTR are proposed. If the new application is funded, the current award will be administratively ended before the new award begins.

Applicant types

Continue researching

Related current grants

All Health & Medical grants →

Tribal Management Grant (TMG) Program

Indian Health Service

The Tribal Management Grant program aims to prepare tribes and tribal organizations for assuming all or part of existing Indian Health Service programs functions services and activities under the Public Law 93 638 Indian Self Determination and Education Assistance Act as amended and to further devel

Improving The Capacity of Tribal Communities to Identify Emerging Drug Threats

Office of National Drug Control Policy

This project would fund researchers to address key impediments or challenges that Tribal communities face related to their capacity to identify emerging drug threats and conduct a pilot project to help these communities improve their capacity to detect and respond to emerging drug threats.

Nonfatal Overdoses in Emergency Departments: Bridging Patient Characteristics, Biospecimen Toxicology, and Drug Supply Composition

Office of National Drug Control Policy

This research project will help build local and national drug consumption surveillance, identify gaps in existing drug testing protocols, facilitate information exchange across public health and public safety organizations, and help coordinate an informed response to address the drug crisis.

Pediatric Disaster Care Centers of Excellence Program Cooperative Agreement

Assistant Secretary for Preparedness and Response

The purpose of this NOFO is to fund four PEDs COEs to:Develop a coordinated pediatric disaster care capability for pediatric patient care in disasters.Strengthen pediatric disaster preparedness plans and health care system coordination related to pediatric medical surge in disasters.Enhance statewid